Low-dose metronomic cisplatin as an antiangiogenic and anti-inflammatory strategy for cancer
Hiroshi Kikuchi, Nako Maishi, Li Yu, Zi Jia, Cong Li, Masumi Sato, Ryo Takeda, Keita Ishizuka, Yasuhiro Hida, Nobuo Shinohara, Kyoko Hida
Topics & Concepts
MedicineChemotherapyCisplatinAngiogenesisCancer researchGemcitabineMetastasisCancerPharmacologyInternal medicineOncologyAngiogenesis and VEGF in CancerChemotherapy-induced organ toxicity mitigationCancer, Hypoxia, and Metabolism